Inactive Instrument

News Veru Inc Nasdaq

Equities

US3144621022

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

HC Wainwright Adjusts Veru Price Target to $3 From $2, Maintains Buy Rating	May. 06	MT
Veru to Present at the GLP-1 Based Therapeutics Summit	May. 02	AQ
Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024	May. 01	AQ
Veru : Corporate Presentation, May 2024	Apr. 30	PU
Veru Enrolls First Patients in Phase 2b Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss	Apr. 30	AQ
Veru Inc. Enrolls First Patients in Phase 2b Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss	Apr. 30	CI
Veru to Present at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting on May 9-11	Apr. 25	AQ
Oppenheimer Cuts Veru Price Target to $5 From $7, Maintains Outperform Rating	Apr. 15	MT
Veru Announces Date of 2024 Annual Meeting of Shareholders	Apr. 01	AQ
Veru Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	Apr. 01	CI
Raymond James Starts Very With Outperform Rating, $3 Price Target	Mar. 28	MT
Veru Reschedules Annual Meeting of Shareholders	Mar. 25	AQ
Veru Reschedules Annual Meeting of Shareholders	Mar. 22	AQ
Certain Options of Veru Inc. are subject to a Lock-Up Agreement Ending on 13-MAR-2024.	Mar. 12	CI
Certain Common Stock of Veru Inc. are subject to a Lock-Up Agreement Ending on 13-MAR-2024.	Mar. 12	CI
Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program for High Quality Weight Loss	Mar. 12	AQ
Veru Inc. Appoints Louis Aronne as Chief Medical Advisor and A Member of the Scientific Advisory Board	Mar. 12	CI
Veru Announces Notification from Nasdaq Related to Delayed Quarterly Report on Form 10-Q	Feb. 27	AQ
Healthcare Innovations and Collaborations Fuel Industry Expansion Stocks Under $1 Look Now! OCGN, VTAK, RSCI, VERU, AGEN	Feb. 21	AQ
Veru Announces New Scientific Advisory Board for its Enobosarm Program for High Quality Weight Loss	Feb. 20	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Veru Inc Nasdaq

Equities

US3144621022

Summary

Filters